Why the study?
Does intravenous propranolol alter arterial compliance differently in patients with hyperkinetic versus normokinetic borderline hypertension?
Population
58 patients with borderline hypertension, comprising 32 with high cardiac output and 26 control subjects…
Comparison
0.2 mg/kg intravenous propranolol vs Baseline measurements and comparison between…
Design
Cross-sectional
Follow-up
Acute
Authors
Loading...
Supports beta-adrenergic mediation of compliance differences; hypothesis-generating for targeted beta-blockade in hyperkinetic borderline hypertension.
Does intravenous propranolol alter arterial compliance differently in patients with hyperkinetic versus normokinetic borderline hypertension?
Disparities in vascular beta-adrenergic tone likely contribute to differences in arterial compliance between hyperkinetic and normokinetic borderline hypertensive patients.
Pétrin et al. (1989) studied this question.